Bristol Myers Squibb signals beyond the news: 71+ signals from 8 sources
The latest Bristol Myers Squibb signal on this page is from Sep 29, 2026 (Patents): "Bristol-Myers Squibb Company's patent output is slowing: 74 grants in the past year, 4 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).
- Signals
- 71+
- Sources
- 8
- Last 90 days
- 46
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Bristol Myers Squibb signals by source
71+ signals for Bristol Myers Squibb across 8 sources.
Patents · Patent pace
Bristol-Myers Squibb Company's patent output is slowing: 74 grants in the past year, 4 in the past 30 days.
Over the past year Bristol-Myers Squibb Company received 74 US patent grants, concentrated in artificial intelligence / machine learning and software / computing; the recent pace (13 in 90 days) is slowing versus its trailing baseline.
- Grants, 12 months
- 74
- Grants, 90 days
- 13
- Grants, 30 days
- 4
- Pace
- Decelerating
Patents · Patent grant
Bristol-Myers Squibb was granted a patent for anti-CCR8 cancer antibodies.
In September 2026 Bristol-Myers Squibb patented antibody treatments for targeting CCR8-bearing cells in cancer therapy, either alone or alongside other treatments.
- Patent title
- Anti-CCR8 antibodies for treating cancer
- Grant date
- Sep 29, 2026
- Inventors
- Ruth Yin-Zong Lan, Olufemi A. Adelakun, Ishita Barman, Joseph Richard Campbell
Reddit · Customer feedback
A commenter criticizes Bristol Myers Squibb for a lack of written documentation like SOPs and for siloing departments, which causes significant issues during study closure.
Post: "Sponsor/FSP Rankings"
- Subreddit
- r/clinicalresearch
- Upvotes
- 24
- Comments
- 46
- Sentiment
- Negative
Reddit · Layoffs
Bristol Myers Squibb laid off 265 employees in New Jersey as part of an ongoing corporate reorganization.
Post: "Layoff Tracker: BMS says goodbye to 265 New Jersey staff as reorg rolls on"
- Subreddit
- r/biotech
- Upvotes
- 186
- Comments
- 36
- Sentiment
- Negative
Podcasts · Sponsorship
Bristol Myers Squibb sponsors Tales from the Heart
Ask your healthcare provider about the latest FDA-approved treatment, Mycorzo, Afacampin. A once-daily pill for adults with symptomatic OHCM to improve functional capacity and symptoms... Learn more at MyCorso.com or call 1-833-697-8796.
- Podcast
- Tales from the Heart
- Episode
- A New HCM Treatment Takes Shape
Web traffic · Traffic snapshot
bms.com received 1M monthly visits with traffic from 5 countries.
Minimal AI traffic at 0.6% (~6,496 visits). Top: chatgpt.com (71%), claude.ai (1%).
- Monthly visits
- 1,021,278
- Month over month
- -7.1%
- 3-month change
- -0.1%
- Global rank
- 42,369
Glassdoor · Layoff mentions
Widespread layoffs and outsourcing are impacting employee morale and job security
Multiple employees report widespread layoffs, workforce reduction, and outsourcing projects as a cost-cutting strategy, leading to job security concerns and toxicity.
- Overall rating
- 3.7 of 5
- CEO approval
- 67%
- Reviews read
- 10
- Review window
- Aug 27, 2026 to Sep 8, 2026
X (Twitter)
Bristol-Myers Squibb announces positive Phase 2 trial results for a CAR T-Cell Therapy for multiple myeloma.
#MEDIA: Announcing positive topline results from a Phase 2 trial of an investigational #CARTCellTherapy for certain patients with relapsed or refractory multiple myeloma. https://t.co/WFRePRZvwZ https://t.co/rUTxnocMYJ
- Account
- @bmsnews
- Views
- 2,165
- Likes
- 15
- Reposts
- 3
Website changes · Feature update
The company’s pipeline pipeline count decreased from 50 to 49 compounds in development while disease areas remained at 40+.
The homepage changed “AS OF APRIL 30, 2026 50 Compounds in development 40+ Disease areas being studied” to “AS OF JULY 30, 2026 49 Compounds in development 40+ Disease areas being studied.”
- Page
- /
LinkedIn
Wishing everyone a happy and healthy New Year!
Wishing everyone a happy and healthy New Year! Here’s to building on what we’ve learned and delivering meaningful progress for patients around the world in 2026. #OneBMS
- Likes
- 922
- Comments
- 14
- Tags
- Patient Experience, Medical Research, Corporate Strategy
Showing 10 of 71+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Bristol Myers Squibb with the Signal API
One POST /v1/companies/enrich call with bms.com returns Bristol Myers Squibb signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "bms.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Bristol Myers Squibb other signals
What signals does Autobound track for Bristol Myers Squibb besides news and filings?
What are people saying about Bristol Myers Squibb online?
What do employees say about working at Bristol Myers Squibb?
Has Bristol Myers Squibb been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .